Cardiome Pharma Corp., of Vancouver, British Columbia, executed a purchase agreement with Lincoln Park Capital Fund LLC (LPC), a Chicago-based institutional investor, to purchase up to $20 million worth of common shares in the capital of the company. Under the terms, Cardiome can sell the amount to LPC from time to time over the 24-month term of the purchase agreement.